90
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Association of A313G glutathione S-transferase P1 germline polymorphism with susceptibility to de novo myelodysplastic syndrome

, , , , , , , , & show all
Pages 1756-1761 | Received 21 Aug 2012, Accepted 22 Dec 2012, Published online: 28 Jan 2013

References

  • Tefferi A, Vardiman JV. Myelodysplastic syndromes. N Engl J Med 2009;361:1872–1885.
  • Benett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of myelodysplastic syndromes. Br J Haematol 1982;51: 189–193.
  • West RR, Stanfford DA, Farrow A, et al. Occupational and environmental exposures and myelodysplasia: a case–control study. Leuk Res 1995;19:127–131.
  • Warlick ED, Smith BD. Myelodysplastic syndromes: review of pathophysiology and current novel treatment approaches. Current Cancer Drug Targets 2007;7:541––558.
  • Ketterer B. The protective role of glutathione transferases in mutagenesis and carcinogenesis. Mutat Res 1988;202:343–361.
  • Mannervik B, Awasthi YC, Board PG, et al. Nomenclature for human glutathione transferases. Biochem J 1992;282:305–306.
  • Moscow JA, Fairchild CR, Madden MJ, et al. Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res 1989;49:1422–1428.
  • Hengstler JG, Arand M, Herrero ME, et al. Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase, and sulfotransferases: influence on cancer susceptibility. Recent Results Cancer Res 1998;154:47–85.
  • Perera F. Molecular epidemiology:insights into cancer susceptibility, risk assessment, and prevention. J Natl Cancer Inst 1996;88:496–509.
  • Howie AF, Forrester LM, Glancey MJ, et al. Glutathione S-transferase and glutathione peroxidase expression in normal and tumor human tissues. Carcinogenesis 1990;11:451–458.
  • Mannervik B, Castro VM, Danielson UH, et al. Expression of class pi glutathione transferase in human malignant melanoma cells. Carcinogenesis 1987;8:1929–1932.
  • Shea TC, Kelley SL, Henner WD. Identification of an anionic form of glutathione transferase present in many human tumors and human tumor cell lines. Cancer Res 1988;48:527–533.
  • Adler V, Yin Z, Fuchs SY, et al. Regulation of JNK signaling by GSTp. EMBO J 1999;18:1321–1334.
  • Wu Y, Fan Y, Xue B, et al. Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Oncogene 2006;25:5787–5800.
  • Laborde E. Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death. Cell Death Differ 2010;17:1373–1380.
  • Tew KD, Townsend DM. Regulatory functions of glutathione S-transferase P1-1 unrelated to detoxification. Drug Metab Rev 2011;43:179–193.
  • Raza A, Galili N, Callander N, et al. Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome. J Hematol Oncol 2009;13:2–20.
  • Ali-Osman F, Akande O, Antoun G, et al. J Biol Chem 1997;272:10004–10012.
  • Watson MA, Stewart RK, Smith GBJ, Massey TE, Bell DA. Human glutathione S-transferase P1 polymorphisms:relationships to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 1998;19:275–280.
  • Hohaus S, Di Ruscio A, Di Febo A, et al. Glutathione S-transferase P1 genotype and prognosis in Hodgkin's lymphoma. Clin Cancer Res 2005;11:2175–2179.
  • Harries LW, Stubbins MJ, Forman D, et al. Identification of genetic polymorphisms at the glutathione S-transferase k locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 1997;18:641–644.
  • Fabiani E, D’Alò F, Scardocci A, et al. Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes. Leuk Res 2009;33:1068–1071.
  • Maggini V, Buda G, Galimberti S, et al. Lack of association of NQO1 and GSTP1 polymorphisms with multiple myeloma risk. Leuk Res 2008;32:988–990.
  • Loktionov A, Watson MA, Gunter M, et al. Glutathione-S-transferase gene polymorphisms in colorectal cancer patients: interaction between GSTM1 and GSTM3 allele variants as a risk-modulating factor. Carcinogenesis 2001;22:1053–1060.
  • Sachse C, Smith G, Wilkie MJ, et al. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis 2002;23:1839–1849.
  • Landi S, Gemignani F, Moreno V, et al. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer. Pharmacogenet Genomics 2005;15:535–546.
  • Martinez C, Martin F, Fernandez JM, et al. Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans. Pharmacogenomics 2006;7:711–718.
  • Vlaykova T, Miteva L, Gulubova M, et al. Ile105Val GSTP1 polymorphism and susceptibility to colorectal carcinoma in Bulgarian population. Int J Colorectal Dis 2007;22:1209–1215.
  • Kury S, Buecher B, Robiou-du-Pont S, et al. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study. BMC Cancer 2008;8:326.
  • Gao Y, Pan X, Su T, et al. Glutathione S-transferase P1 Ile105Val polymorphism and colorectal cancer risk: a meta-analysis and HuGE review. Eur J Cancer 2009;45:3303–3314.
  • Stanulla M, Schrappe M., Brechlin AM, et al. Polymorphism with in glutathione S-trasferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia:a case control study. Blood 2000;95:1222–1228.
  • Dunna NR, Vuree S, Kagita S, et al. Association of GSTP1 gene (I105V) polymorphism with acute leukaemia. J Genet 2012;91: 60–63.
  • Allan JM, Wild CP, Rollinson S, et al. Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy induced leukemia. Proc Natl Acad Sci USA 2001;98:11592–11597.
  • Yri OE, Ekstrom PO, Hilden V, et al. Polymorphisms in genes encoding interleukin-10 and drug metabolizing enzymes GSTP1, GSTT1, GSTA1 and UGT1A1 influence risk and outcome in Hodgkin lymphoma. Leuk Lymphoma 2012;53:1934–1944.
  • Sasai Y, Horiike S, Misawa S, et al. Genotype of glutathione S-transferase and other genetic configurations in myelodysplasia. Leuk Res 1999;23:975–981.
  • Shaffer LG, Slovak ML, Campell LJ, eds. ISCN 2009: an international system for human cytogenetic nomenclature. Basel, Switzerland: S. Karger; 2009.
  • Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997;89:2079–2088.
  • Board PG, Webb GC, Coggan M. Isolation of a cDNA clone and localization of the human glutathione S-transferase 3 gene to chromosome bands 11q13 and 12q13-14. Ann Hum Genet 1989;53: 205–213.
  • Kuendgen A, Matsuda A, Germing U. Differences in epidemiology of MDS between Western and Eastern countries: ethnic differences or environmental influence? Leuk Res 2007;31:103–104.
  • Tremblay S, Pintor dos Reis P, Bradley G, et al. Young patients with oral squamous cell carcinoma: study of the involvement of GSTP1 and deregulation of the Fanconi anemia genes. Arch Otolaryngol Head Neck Surg 2006;132:958–966.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.